Cargando…
Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention
OBJECTIVE: To investigate the preventive effect of hydration combined with reduced glutathione on contrast-induced nephropathy (CIN) after coronary intervention therapy in elderly Chinese patients with diabetes. METHODS: Patients with diabetes aged ≥65 years, who received percutaneous coronary inter...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705794/ https://www.ncbi.nlm.nih.gov/pubmed/33243032 http://dx.doi.org/10.1177/0300060520964017 |
_version_ | 1783617020369043456 |
---|---|
author | Wang, Lingqing Xu, Enguo Ren, Shijia Gu, Xingjian Zheng, Jiping Yang, Jianguang |
author_facet | Wang, Lingqing Xu, Enguo Ren, Shijia Gu, Xingjian Zheng, Jiping Yang, Jianguang |
author_sort | Wang, Lingqing |
collection | PubMed |
description | OBJECTIVE: To investigate the preventive effect of hydration combined with reduced glutathione on contrast-induced nephropathy (CIN) after coronary intervention therapy in elderly Chinese patients with diabetes. METHODS: Patients with diabetes aged ≥65 years, who received percutaneous coronary intervention (PCI) between 1 August 2016 and 31 December 2018, were enrolled and randomized into two groups: patients treated with hydration combined with reduced glutathione (treatment group) and patients who received hydration alone (controls). Serum creatinine and creatinine clearance levels were measured in all patients before PCI and then daily for 3 days after PCI. Occurrence of CIN (the primary endpoint) was defined as serum creatinine value 25% or 44.2 mmol/l (0.5 mg/dl) above baseline at 72 h after an exposure to contrast medium. RESULTS: A total of 396 patients were included (treatment group, n = 204; and controls, n = 192). The CIN occurrence rate in the treatment and control group was 5.88% and 6.77%, respectively, with no statistically significant between-group difference. CONCLUSION: In elderly patients with diabetes receiving PCI, the risk of CIN was not effectively lowered by hydration combined with reduced glutathione. |
format | Online Article Text |
id | pubmed-7705794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-77057942020-12-07 Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention Wang, Lingqing Xu, Enguo Ren, Shijia Gu, Xingjian Zheng, Jiping Yang, Jianguang J Int Med Res Prospective Clinical Research Report OBJECTIVE: To investigate the preventive effect of hydration combined with reduced glutathione on contrast-induced nephropathy (CIN) after coronary intervention therapy in elderly Chinese patients with diabetes. METHODS: Patients with diabetes aged ≥65 years, who received percutaneous coronary intervention (PCI) between 1 August 2016 and 31 December 2018, were enrolled and randomized into two groups: patients treated with hydration combined with reduced glutathione (treatment group) and patients who received hydration alone (controls). Serum creatinine and creatinine clearance levels were measured in all patients before PCI and then daily for 3 days after PCI. Occurrence of CIN (the primary endpoint) was defined as serum creatinine value 25% or 44.2 mmol/l (0.5 mg/dl) above baseline at 72 h after an exposure to contrast medium. RESULTS: A total of 396 patients were included (treatment group, n = 204; and controls, n = 192). The CIN occurrence rate in the treatment and control group was 5.88% and 6.77%, respectively, with no statistically significant between-group difference. CONCLUSION: In elderly patients with diabetes receiving PCI, the risk of CIN was not effectively lowered by hydration combined with reduced glutathione. SAGE Publications 2020-11-26 /pmc/articles/PMC7705794/ /pubmed/33243032 http://dx.doi.org/10.1177/0300060520964017 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Prospective Clinical Research Report Wang, Lingqing Xu, Enguo Ren, Shijia Gu, Xingjian Zheng, Jiping Yang, Jianguang Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention |
title | Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention |
title_full | Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention |
title_fullStr | Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention |
title_full_unstemmed | Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention |
title_short | Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention |
title_sort | reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention |
topic | Prospective Clinical Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705794/ https://www.ncbi.nlm.nih.gov/pubmed/33243032 http://dx.doi.org/10.1177/0300060520964017 |
work_keys_str_mv | AT wanglingqing reducedglutathionedoesnotfurtherreducecontrastinducednephropathyinelderlypatientswithdiabetesreceivingpercutaneouscoronaryintervention AT xuenguo reducedglutathionedoesnotfurtherreducecontrastinducednephropathyinelderlypatientswithdiabetesreceivingpercutaneouscoronaryintervention AT renshijia reducedglutathionedoesnotfurtherreducecontrastinducednephropathyinelderlypatientswithdiabetesreceivingpercutaneouscoronaryintervention AT guxingjian reducedglutathionedoesnotfurtherreducecontrastinducednephropathyinelderlypatientswithdiabetesreceivingpercutaneouscoronaryintervention AT zhengjiping reducedglutathionedoesnotfurtherreducecontrastinducednephropathyinelderlypatientswithdiabetesreceivingpercutaneouscoronaryintervention AT yangjianguang reducedglutathionedoesnotfurtherreducecontrastinducednephropathyinelderlypatientswithdiabetesreceivingpercutaneouscoronaryintervention |